Rituximab and Autologous Effector Lymphocytes in Non-Hodgkin Follicular Lymphoma in Response to First Line Chemotherapy
Conditions
- Follicular Lymphoma
- Follicular Non-Hodgkin´s Lymphoma
- Autologous Effector Lymphocytes
Interventions
- BIOLOGICAL: Autologous effector lymphocytes expanded ex-vivo
Sponsor
Clinica Universidad de Navarra, Universidad de Navarra
Collaborators